Feedback / Questions
LBL-047 - Leads Biolabs
https://www.prnewswire.com/news-releases/first-in-class-potential-fda-clears-ind-application-for-lbl-047-an-anti-bdca2taci-bispecific-fusion-protein-developed-by-leads-biolabs-302562528.html
Sep 22, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next